Peter Langenstroer

1.8k total citations
57 papers, 1.2k citations indexed

About

Peter Langenstroer is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Peter Langenstroer has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 22 papers in Surgery and 10 papers in Urology. Recurrent topics in Peter Langenstroer's work include Bladder and Urothelial Cancer Treatments (14 papers), Urological Disorders and Treatments (8 papers) and Renal cell carcinoma treatment (7 papers). Peter Langenstroer is often cited by papers focused on Bladder and Urothelial Cancer Treatments (14 papers), Urological Disorders and Treatments (8 papers) and Renal cell carcinoma treatment (7 papers). Peter Langenstroer collaborates with scholars based in United States. Peter Langenstroer's co-authors include Galen M. Pieper, Wolfgang Siebeneich, William A. See, Ellen Shapiro, Herbert Lepor, Frank P. Begun, Michael L. Guralnick, Stephen T. O’Rourke, Davide Antonio Mei and Barbara J. Divish and has published in prestigious journals such as Journal of Clinical Oncology, The FASEB Journal and The Journal of Urology.

In The Last Decade

Peter Langenstroer

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Langenstroer United States 20 438 368 277 237 176 57 1.2k
Harbajan Chadha‐Boreham Switzerland 16 381 0.9× 712 1.9× 143 0.5× 177 0.7× 139 0.8× 23 1.6k
Brúno Nobili Italy 32 641 1.5× 300 0.8× 245 0.9× 559 2.4× 119 0.7× 73 2.4k
Hagop S. Aynedjian United States 26 468 1.1× 333 0.9× 174 0.6× 505 2.1× 213 1.2× 45 1.8k
Noritaka Kawada Japan 21 234 0.5× 264 0.7× 294 1.1× 682 2.9× 410 2.3× 40 2.1k
Francesco Berardinelli Italy 26 437 1.0× 574 1.6× 261 0.9× 829 3.5× 84 0.5× 88 1.9k
G. M. Aber United Kingdom 18 160 0.4× 144 0.4× 289 1.0× 221 0.9× 79 0.4× 65 1.3k
Noriyuki Iwamoto Japan 29 179 0.4× 175 0.5× 782 2.8× 680 2.9× 396 2.3× 64 1.9k
B. M. Brenner United States 24 288 0.7× 455 1.2× 285 1.0× 495 2.1× 505 2.9× 34 2.7k
B. D. Myers United States 13 166 0.4× 261 0.7× 234 0.8× 486 2.1× 212 1.2× 16 2.0k
Giulio A. Cinotti Italy 24 245 0.6× 218 0.6× 187 0.7× 431 1.8× 226 1.3× 70 2.0k

Countries citing papers authored by Peter Langenstroer

Since Specialization
Citations

This map shows the geographic impact of Peter Langenstroer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Langenstroer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Langenstroer more than expected).

Fields of papers citing papers by Peter Langenstroer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Langenstroer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Langenstroer. The network helps show where Peter Langenstroer may publish in the future.

Co-authorship network of co-authors of Peter Langenstroer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Langenstroer. A scholar is included among the top collaborators of Peter Langenstroer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Langenstroer. Peter Langenstroer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allen, Andrew E., et al.. (2024). Glomus tumor with malignant features: A case report and review of the literature. Urology Case Reports. 55. 102774–102774.
2.
Li, Nathan, et al.. (2021). Staple Line Erosion in a Neobladder Causing Postoperative Hematuria. Cureus. 13(6). e15450–e15450.
3.
Taylor, Jacob, James Wysock, Andrew T. Lenis, et al.. (2020). Primary Robot-assisted Retroperitoneal Lymph Node Dissection for Men with Nonseminomatous Germ Cell Tumor: Experience from a Multi-institutional Cohort. European Urology Focus. 7(6). 1403–1408. 13 indexed citations
4.
Milowsky, Matthew I., Nancy B. Davis, Chunkit Fung, et al.. (2020). 801TiP A phase II study of cabozantinib in combination with atezolizumab as neoadjuvant treatment for muscle-invasive bladder cancer (ABATE). Annals of Oncology. 31. S607–S607. 2 indexed citations
5.
Piotrowski, Joshua, et al.. (2019). Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma. Urology. 132. 136–142. 22 indexed citations
6.
Jacobsohn, Kenneth, Peter Langenstroer, R Corey O'Connor, et al.. (2015). Initial experience with ketamine-based analgesia in patients undergoing robotic radical cystectomy and diversion. Canadian Urological Association Journal. 9(5-6). 367–367. 2 indexed citations
7.
Langenstroer, Peter, et al.. (2014). Surgical reduction of scrotal massive localized lymphedema (MLL) in obesity. Journal of Plastic Reconstructive & Aesthetic Surgery. 67(12). 1719–1725. 21 indexed citations
8.
9.
Guralnick, Michael L., et al.. (2013). Duloxetine for the treatment of post-prostatectomy stress urinary incontinence. Canadian Urological Association Journal. 7(5-6). 260–260. 14 indexed citations
10.
Almassi, G. Hossein, et al.. (2009). Deep Hypothermic Circulatory Arrest for a Patient With Known Cold Agglutinins. The Annals of Thoracic Surgery. 88(4). 1326–1327. 13 indexed citations
11.
See, William A., Guangjian Zhang, Fanghong Chen, et al.. (2008). Bacille‐Calmette Guèrin induces caspase‐independent cell death in urothelial carcinoma cells together with release of the necrosis‐associated chemokine high molecular group box protein 1. British Journal of Urology. 103(12). 1714–1720. 38 indexed citations
12.
Langenstroer, Peter, et al.. (2008). Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells. The Journal of Urology. 181(2). 615–620. 21 indexed citations
13.
Datta, Milton W., et al.. (2006). Intra‐abdominal desmoid tumor following retroperitoneal lymph node dissection for testicular germ cell tumor. International Journal of Urology. 13(1). 84–86. 6 indexed citations
14.
Langenstroer, Peter, Peter R. Carroll, & J. Brantley Thrasher. (2005). CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF UNSTAGEABLE PROSTATE CANCER: ANALYSIS OF THE CaPSURE™ DATABASE. The Journal of Urology. 174(1). 118–120. 6 indexed citations
15.
Tawfik, Ossama, et al.. (2003). Renal-ovarian axis: a case report and review. Urology. 62(4). 749–749. 10 indexed citations
16.
Langenstroer, Peter & William A. See. (2000). The role of a second transurethral resection for high-grade bladder cancer. Current Urology Reports. 1(3). 204–207. 2 indexed citations
17.
Assimos, Dean G., et al.. (1999). Guaifenesin- and Ephedrine-Induced Stones. Journal of Endourology. 13(9). 665–667. 39 indexed citations
18.
Pieper, Galen M., Peter Langenstroer, & Wolfgang Siebeneich. (1997). Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovascular Research. 34(1). 145–156. 156 indexed citations
19.
Balcom, Anthony H., et al.. (1997). Initial Experience With Home Therapeutic Electrical Stimulation for Continence in the Myelomeningocele Population. The Journal of Urology. 1272–1276. 2 indexed citations
20.
Langenstroer, Peter, et al.. (1996). Annular constriction of the rectum secondary to transitional cell carcinoma of the bladder. Urology. 47(3). 442–444. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026